Ansel Hillmer, PhD, and Eric Webb, PhD, receives SNMMI Mars Shot Research Fund Award
Grant and Award Announcement
In honor of Alzheimer's Awareness Month, we’re exploring the science and stories surrounding Alzheimer’s disease.
Updates every hour. Last Updated: 21-Jun-2026 17:15 ET (21-Jun-2026 21:15 GMT/UTC)
A new study in Science Advances found that more than 155,000 US deaths between March 2020 and December 2021 were not officially recorded as COVID-19 deaths, which equates to 19 percent more deaths due to COVID-19 than federal records indicate. These unrecognized COVID-19 deaths disproportionately burdened certain populations more than others, including racial and ethnic minorities, as well as people who were low-income, had preexisting health conditions, lived in the South, or did not have a high school education.
Older people with a genetic risk of Alzheimer's disease did not experience the expected increase in cognitive decline and dementia risk if they consumed relatively large amounts of meat. This is shown in a new study from Karolinska Institutet published in JAMA Network Open. The results may contribute to the development of more individually tailored dietary advice.
New treatments for neurodegenerative diseases like Alzheimer’s, Parkinson’s, and motor neurone disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University of Essex. Using artificial intelligence, an international team of scientists has created tiny antibody fragments that can be made directly inside human cells, where they bind to proteins linked to disease. These redesigned molecules will be made freely available to other scientists now the research has been published in Nature Communications.